E. Jason Abel, MD, FACS close

E. Jason Abel, MD, FACS Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Abel is board certified by the American Board of Urology and specializes in the surgical treatment of urologic malignancies. He has advanced training to surgically manage all types of genitourinary cancers, including prostate cancer, bladder cancer, kidney cancer, testis cancer and penile cancer.


Dr. Abel performs open and laparoscopic surgery, including surgery using the daVinci robot. His philosophy is to provide maximal quality of life to patients by using minimally invasive approaches to cancer therapy whenever appropriate. He has a special interest in the treatment of localized and locally advanced kidney cancer.



University Hospital
(608) 263-4757 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Urology

Professional Certifications and Education

Board Certification Urology

Urologic Oncology, M.D. Anderson Cancer Center, Houston, TX

Residency University of Utah Hospital, Salt Lake City, UT
Internship University of Utah Hospital, Salt Lake City, UT
Medical School University of Texas Medical School, Houston, TX

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Abel conducts clinical, translational and basic research in urologic oncology. He currently is involved in several projects focusing on the development and metastasis of kidney cancer.

PubMed Articles
Wetley KA Abel EJ Dreyfuss LD Huang W Brace CL Wells SA CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol (NY) . 2020 Sep;45(9):2810-2824
[PubMed ID: 32715335]
Swietlik JF Knott EA Longo KC Abel EJ Wells SA Lubner MG Laeseke PF McCormick T Hinshaw JL Lee FT Jr Ziemlewicz TJ Microwave Ablation of Adrenal Tumors in Patients With Continuous Intra-Arterial Blood Pressure Monitoring Without Prior Alpha-Adrenergic Blockade: Safety and Efficacy. Cardiovasc Intervent Radiol . 2020 Sep;43(9):1384-1391
[PubMed ID: 32529338]
Dreyfuss LD Master VA Raman JD Spiess PE Wells SA Merrill SB Peyton CC Sankar D Sohl B Patil D Shapiro DD Allen GO Abel EJ Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma. Urology . 2020 Aug 8;
[PubMed ID: 32781079]
Shapiro DD Abel EJ Renal cell carcinoma with isolated lymph node metastases should be reclassified as stage IV. Cancer . 2020 Jul 1;126(13):2965-2967
[PubMed ID: 32329898]
Abel EJ Editorial Comment. J Urol . 2020 Mar;203(3):503
[PubMed ID: 31774732]
Miller BL Abel EJ Allen G Schumacher JR Jarrard D Downs T Richards KA Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis. Am J Clin Exp Urol . 2020;8(1):28-37
[PubMed ID: 32211451]
Peyton CC Abel EJ Chipollini J Boulware DC Azizi M Karam JA Margulis V Master VA Matin SF Raman JD Sexton WJ Wood CG Spiess PE The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy. Eur Urol Focus . 2020 Jan 15;6(1):104-111
[PubMed ID: 30206003]
Elmaraghi S Chen TJ Heckman JE Shiau JM Williams DH Abel EJ Afifi AM Functional penile replantation after traumatic avulsion amputation below the pubis: A case report. Microsurgery . 2020 Jan;40(1):70-73
[PubMed ID: 30714225]
Kim NY Lubner MG Nystrom JT Swietlik JF Abel EJ Havighurst TC Silverman SG McGahan JP Pickhardt PJ Utility of CT Texture Analysis in Differentiating Low-Attenuation Renal Cell Carcinoma From Cysts: A Bi-Institutional Retrospective Study. AJR Am J Roentgenol . 2019 Dec;213(6):1259-1266
[PubMed ID: 31386573]
Dreyfuss LD Wells SA Best SL Hedican SP Ziemlewicz TJ Lubner MG Hinshaw JL Lee FT Jr Nakada SY Abel EJ Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma. Urology . 2019 Dec;134:148-153
[PubMed ID: 31465794]
Maciolek KA Abel EJ Posielski NM Hinshaw JL Lubner MG Lee FT Jr Ziemlewicz TJ Wells SA Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma. Eur Radiol . 2019 Nov;29(11):6319-6329
[PubMed ID: 31016448]
Flack CK Calaway AC Miller BL Picken MM Gondim DD Idrees MT Abel EJ Gupta GN Boris RS Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma. Urol Oncol . 2019 Nov;37(11):811.e17-811.e21
[PubMed ID: 31451335]
Olson MC Abel EJ Mankowski Gettle L Contrast-Enhanced Ultrasound in Renal Imaging and Intervention. Curr Urol Rep . 2019 Oct 17;20(11):73
[PubMed ID: 31624973]
Shapiro DD Abel EJ Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors. Curr Opin Urol . 2019 Sep;29(5):513-520
[PubMed ID: 31305274]
Knott EA Swietlik JF Longo KC Watson RF Green CM Abel EJ Lubner MG Hinshaw JL Smolock AR Xu Z Lee FT Jr Ziemlewicz TJ Robotically-Assisted Sonic Therapy for Renal Ablation in a Live Porcine Model: Initial Preclinical Results. J Vasc Interv Radiol . 2019 Aug;30(8):1293-1302
[PubMed ID: 31130365]
Scrima AT Lubner MG Abel EJ Havighurst TC Shapiro DD Huang W Pickhardt PJ Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers. Abdom Radiol (NY) . 2019 Jun;44(6):1999-2008
[PubMed ID: 29804215]
Posielski NM Bui A Wells SA Best SL Gettle LM Ziemlewicz TJ Lubner MG Hinshaw JL Lee FT Jr Allen GO Nakada SY Abel EJ Risk Factors for Complications and Nondiagnostic Results following 1,155 Consecutive Percutaneous Core Renal Mass Biopsies. J Urol . 2019 Jun;201(6):1080-1087
[PubMed ID: 30741848]
Best SL Liu Y Keikhosravi A Drifka CR Woo KM Mehta GS Altwegg M Thimm TN Houlihan M Bredfeldt JS Abel EJ Huang W Eliceiri KW Collagen organization of renal cell carcinoma differs between low and high grade tumors. BMC Cancer . 2019 May 23;19(1):490
[PubMed ID: 31122202]
Wang JH Sierra P Richards KA Abel EJ Allen GO Downs TM Jarrard DF Impact of bilateral biopsy-detected prostate cancer on an active surveillance population. BMC Urol . 2019 Apr 23;19(1):26
[PubMed ID: 31014300]
Jiménez-Torres JA Virumbrales-Muñoz M Sung KE Lee MH Abel EJ Beebe DJ Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma. EBioMedicine . 2019 Apr;42:408-419
[PubMed ID: 30902740]